DEFITELIO: New Drug Trials Snapshot Posted

A new DRUG TRIALS SNAPSHOT FOR DEFITELIO is now available.

DEFITELIO is a drug for the treatment of hepatic veno-occlusive disease (VOD). Hepatic veno-occlusive disease is a condition in which some of the veins in the liver become blocked, causing swelling and a decrease in blood flow inside the liver, which may lead to liver damage and death.

DEFITELIO is for patients with VOD who have an additional kidney or lung abnormalities after they receive a stem cell transplant from blood or bone marrow called hematopoietic stem cell transplantation (HSCT).

Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.